Publications by authors named "Kerry Reynolds"

Claim this Profile
I
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
Rebecca Karp Leaf, Jodi V Mones, Tushar Shenoy, Mohamed Warsame, Marina Beltrami-Moreira, Kerry Reynolds

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors, Atherosclerotic Cardiovascular Events, and Plaque Progression Among Women With Cancer.
Giselle Alexandra Suero-Abreu, Zsofia D Drobni, Carlos A Gongora, Jana Taron, Julia Karady, Kerry L Reynolds

J Am Heart Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D deficiency is associated with lower overall survival in patients receiving immune checkpoint inhibitors for cancer: A population-based cohort study using the TriNetX database.
Natalie Braun, Natalie Baker, Bryan L Peacker, Ghida El Banna, Lauren Guggina, Kerry L Reynolds

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Ling Zhu, Yee-Ming M Cheung, Cherie Chiang, Emily J Gallagher, Ole-Petter R Hamnvik, Kerry L Reynolds

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double Trouble: A Case Series on Dual Morphology Cutaneous Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors.
Joseph Ebriani, Mike Westmeijer, Bethany Brumbaugh, Allison Holt, Baraa Hijaz, Kerry L Reynolds

Int J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis.
Shruti Gupta, Kavita Mistry, Firasat M Alikhan, Sherley M Mejia, Sagar Sadarangani, Kerry L Reynolds

Kidney Int· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs)" [Best Pract Res Clin Haematol 38 2 2025].
Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, Kerry L Reynolds

Best Pract Res Clin Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy.
Ali Raza Khaki, Kerry L Reynolds, Laura A Petrillo

JCO Oncol Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal and geographic variation in cutaneous immune-related adverse events after treatment with immune checkpoint inhibitors.
Ahmad Rajeh, Katie Roster, Kerry L Reynolds, Nicole R LeBoeuf, Ryan J Sullivan

J Eur Acad Dermatol Venereol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: A multicenter retrospective cohort study.
Baraa A Hijaz, Natalie Braun, Kerry L Reynolds, Yevgeniy R Semenov, Nicole R LeBoeuf

J Am Acad Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Long-Term Survival in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis.
Nikhil Dubey, Chia-Yun Wu, Leyre Zubiri, Magdalena Fay, Sherin J Rouhani, Kerry L Reynolds

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connecting the Dots: Practical Strategies for Academic and Community Oncology Synergy to Advance Multidisciplinary Management in Immunotherapy Toxicity Care.
Danielle Brazel, Vera Kazakova, Magdalena Fay, Kathryn Bollin, Kriti Mittal, Kerry L Reynolds

Am Soc Clin Oncol Educ Book· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of systemic glucocorticoid immunosuppression timing, dose, and duration on overall survival among immune checkpoint inhibitor recipients: a retrospective multicohort study.
Guihong Wan, Nga Nguyen, Charles Lu, Sara Khattab, Boshen Yan, Kerry L Reynolds

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision immunomodulation: Understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs).
Matthew J Hadfield, Ross D Merkin, Sherin J Rouhani, Kerry L Reynolds

Best Pract Res Clin Haematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family Experience With Hospital Care Teams: A Qualitative Investigation.
Kerry A Reynolds, Sarah M Zelazny, Rachel Grob, Andrew M Parker, Mark Schlesinger

Hosp Pediatr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events.
Sara Khattab, Guihong Wan, Suzanne Xu, Cameron Moseley, Matthew Tran, Kerry L Reynolds

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor location as a risk factor for severe immune-related adverse events.
Steven M Blum, Ben Ouyang, Leyre Zubiri, Daniel Leonard, Kamil Slowikowski, Kerry L Reynolds

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Eileen L Chang, Renee Liu, Kiandokht Keyhanian, Katie Huynh, Meghan Berkenstock, Kerry L Reynolds

J Immunother Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management.
Maysa Vilbert, Leyre Zubiri, Meghan J Mooradian, Kerry L Reynolds

JCO Oncol Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy.
Sienna M Durbin, Leyre Zubiri, Katherine Perlman, Chia-Yun Wu, Tristan Lim, Kerry L Reynolds

JAMA Netw Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors.
Cho-Han Chiang, Junmin Song, Kuan-Yu Chi, Yu-Cheng Chang, Nutchapon Xanthavanij, Kerry L Reynolds

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Randomized Trial of an Educational Intervention About Immunotherapy for Patients With Advanced Cancer and Their Caregivers.
Laura A Petrillo, Kelly Hsu, Kedie Pintro, Dustin J Rabideau, Ashley Z Zhou, Kerry L Reynolds

J Natl Compr Canc Netw· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events.
Sara Khattab, Guihong Wan, Suzanne Xu, Cameron Moseley, Matthew Tran, Kerry L Reynolds

medRxiv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Musculoskeletal ultrasound characteristics of checkpoint inhibitor-associated inflammatory arthritis.
Mazen Nasrallah, Greg Challener, Sara Schoenfeld, Mark Matza, Donald Lawrence, Kerry L Reynolds

Semin Arthritis Rheum· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of immunotherapy outcomes in Black patients.
Kerry L Reynolds, Pauline Funchain

Lancet Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis